The cyclin E expression was first reported in low-grade dysplasia (2/21), high grade dysplasia (3/17), adenocarcinoma (5/35) and Barrett’s esophagus (43%) in 60 samples by an immunohistochemistry [21,22]. This evidence concerns the gene CCNE1 and esophageal adenocarcinoma.